Dynamics of antibody responses, cellular immunity, and breakthrough infections among Japanese healthcare workers during the 6 months after receiving two doses of BNT162b2 mRNA vaccine
View ORCID ProfileYoshifumi Uwamino, Toshinobu Kurafuji, Kumiko Takato, Akiko Sakai, Akiko Tanabe, Masayo Noguchi, Yoko Yatabe, Tomoko Arai, Akemi Ohno, Yukari Tomita, Ayako Shibata, Hiromitsu Yokota, Wakako Yamasawa, Ho Namkoong, Yasunori Sato, Naoki Hasegawa, Masatoshi Wakui, Mitsuru Murata, the Keio Donner Project Team
doi: https://doi.org/10.1101/2022.01.29.22270052
Yoshifumi Uwamino
1Department of Laboratory Medicine, Keio University School of Medicine; 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan
2Department of Infectious Diseases, Keio University School of Medicine; 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan
Toshinobu Kurafuji
3Clinical Laboratory, Keio University Hospital; 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan
Kumiko Takato
3Clinical Laboratory, Keio University Hospital; 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan
Akiko Sakai
3Clinical Laboratory, Keio University Hospital; 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan
Akiko Tanabe
3Clinical Laboratory, Keio University Hospital; 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan
Masayo Noguchi
3Clinical Laboratory, Keio University Hospital; 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan
Yoko Yatabe
3Clinical Laboratory, Keio University Hospital; 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan
Tomoko Arai
3Clinical Laboratory, Keio University Hospital; 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan
Akemi Ohno
3Clinical Laboratory, Keio University Hospital; 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan
Yukari Tomita
1Department of Laboratory Medicine, Keio University School of Medicine; 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan
Ayako Shibata
1Department of Laboratory Medicine, Keio University School of Medicine; 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan
Hiromitsu Yokota
3Clinical Laboratory, Keio University Hospital; 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan
Wakako Yamasawa
1Department of Laboratory Medicine, Keio University School of Medicine; 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan
Ho Namkoong
2Department of Infectious Diseases, Keio University School of Medicine; 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan
Yasunori Sato
4Department of Preventive Medicine and Public Health, Keio University School of Medicine; 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan
Naoki Hasegawa
2Department of Infectious Diseases, Keio University School of Medicine; 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan
Masatoshi Wakui
1Department of Laboratory Medicine, Keio University School of Medicine; 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan
Mitsuru Murata
1Department of Laboratory Medicine, Keio University School of Medicine; 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
- Supplement Fig S1, Supplement Fig S2[supplements/270052_file03.docx]
Posted January 30, 2022.
Dynamics of antibody responses, cellular immunity, and breakthrough infections among Japanese healthcare workers during the 6 months after receiving two doses of BNT162b2 mRNA vaccine
Yoshifumi Uwamino, Toshinobu Kurafuji, Kumiko Takato, Akiko Sakai, Akiko Tanabe, Masayo Noguchi, Yoko Yatabe, Tomoko Arai, Akemi Ohno, Yukari Tomita, Ayako Shibata, Hiromitsu Yokota, Wakako Yamasawa, Ho Namkoong, Yasunori Sato, Naoki Hasegawa, Masatoshi Wakui, Mitsuru Murata, the Keio Donner Project Team
medRxiv 2022.01.29.22270052; doi: https://doi.org/10.1101/2022.01.29.22270052
Dynamics of antibody responses, cellular immunity, and breakthrough infections among Japanese healthcare workers during the 6 months after receiving two doses of BNT162b2 mRNA vaccine
Yoshifumi Uwamino, Toshinobu Kurafuji, Kumiko Takato, Akiko Sakai, Akiko Tanabe, Masayo Noguchi, Yoko Yatabe, Tomoko Arai, Akemi Ohno, Yukari Tomita, Ayako Shibata, Hiromitsu Yokota, Wakako Yamasawa, Ho Namkoong, Yasunori Sato, Naoki Hasegawa, Masatoshi Wakui, Mitsuru Murata, the Keio Donner Project Team
medRxiv 2022.01.29.22270052; doi: https://doi.org/10.1101/2022.01.29.22270052
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (671)
- Anesthesia (181)
- Cardiovascular Medicine (2656)
- Dermatology (224)
- Emergency Medicine (400)
- Epidemiology (12248)
- Forensic Medicine (10)
- Gastroenterology (763)
- Genetic and Genomic Medicine (4114)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2666)
- Health Policy (1005)
- Hematology (364)
- HIV/AIDS (853)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (439)
- Neurology (3897)
- Nursing (210)
- Nutrition (578)
- Oncology (2037)
- Ophthalmology (586)
- Orthopedics (241)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1116)
- Primary Care Research (452)
- Public and Global Health (6538)
- Radiology and Imaging (1407)
- Respiratory Medicine (871)
- Rheumatology (411)
- Sports Medicine (343)
- Surgery (451)
- Toxicology (53)
- Transplantation (185)
- Urology (166)